After CAR-T Failed and Leukaemia Came Back Again, His Family Looked Further.
Jake had ETP-ALL — a rare, high-risk leukaemia subtype — and had been through chemotherapy, targeted therapy, and CAR-T in Australia without lasting remission. After multiple relapses and a narrowing of local options, his family searched for a different approach and found one in Beijing.